New FDA Regenerative Medicine Framework is Win-Win for Gene Therapies

Back in November 2017, the FDA announced a comprehensive policy framework for the development and oversight of regenerative medicine products, including no...

https://www.leafscience.org/fda-rmat/

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website, NutritionTheory.org

View all posts by Robert Zinn →